Table 1.
Patients’ clinical characteristics.
| Non-Durable Response (n = 14) |
Durable Response (n = 220) |
p-Value | |
|---|---|---|---|
| Age at diagnosis, year (SD) | 26.3 (9.2) | 28.2 (9.1) | 0.45 |
| Gender, male (%) | 8 (57.1%) | 162 (73.6%) | 0.21 |
| History of smoking, n (%) | 5 (35.7%) | 47 (21.4%) | 0.20 |
| Family history of IBD, n (%) | 0 (0%) | 7 (3.2%) | 1.0 |
| Disease duration, year (SD) | 9.1 (5.5) | 7.5 (3.8) | 0.16 |
| Disease location, n (%) | 0.07 | ||
| Ileal | 7 (50%) | 52 (23.6%) | |
| Colonic | 2 (14.3%) | 31 (14.1%) | |
| Ileocolonic | 5 (35.7%) | 137 (62.3%) | |
| Upper GI involvement, n (%) | 0 (0%) | 11 (5.0%) | 0.39 |
| Disease behavior, n (%) | 0.35 | ||
| Inflammatory | 9 (64.3%) | 163 (74.1%) | |
| Stricturing | 1 (7.1%) | 25 (11.4%) | |
| Penetrating | 4 (28.6%) | 32 (14.5%) | |
| Perianal disease, n (%) | 6 (42.9%) | 85 (38.6%) | 0.75 |
| Combination immunosuppressants, n (%) | 10 (71.4%) | 206 (93.6%) | <0.001 |
| Intestinal resection, n (%) | 6 (42.9%) | 61 (27.7%) | 0.22 |
IBD, inflammatory bowel disease; GI, gastrointestinal.